What You Should Know:

你应该知道的：

–

–

Autonomize AI

自主化人工智能

, a pioneer in AI-driven healthcare solutions, today announced that it raised $28 million in a Series A funding, bringing total capital raised to $32 million to date.

，一家人工智能驱动的医疗保健解决方案的先驱，今天宣布在A轮融资中筹集了2800万美元，截至目前总筹集资金达到了3200万美元。

–   The round was led by

– 本轮由

Valtruis

瓦尔特鲁伊斯

,

，

The Cigna Group Ventures

Cigna集团风险投资

,

，

Tau Ventures

太空风险投资公司

, and other strategic investors.

，以及其他战略投资者。

Asset Management Ventures

资产管理风险投资

,

，

ATX Venture Partners

ATX风险合伙人

and

和

Capital Factory

资本工厂

are among the company’s existing investors who also participated.

参与的还有该公司的现有投资者。

Autonomize AI Secures Funding to Scale Agentic AI for Healthcare Operations Transformation

自主化人工智能获得资金支持，以扩展用于医疗运营转型的代理人工智能。

Autonomize AI, founded in 2022 by Ganesh Padmanabhan and Kris Nair, is advancing a new model of healthcare delivery by addressing operational inefficiencies with its Agentic AI Orchestration platform. The latest round of funding will enable the company to scale its solutions and help healthcare organizations reduce administrative complexity, enhance clinician capacity, and improve care delivery outcomes..

Autonomize AI由Ganesh Padmanabhan和Kris Nair于2022年创立，正在通过其Agentic AI编排平台解决运营效率低下的问题，推动一种全新的医疗交付模式。最新一轮融资将使该公司能够扩展其解决方案，帮助医疗机构降低行政复杂性、提升临床医生能力并改善护理交付效果。

Unlike traditional automation tools or generic generative AI platforms, Autonomize AI offers a purpose-built, healthcare-native orchestration engine. Its pre-trained, deployable AI agents function as intelligent Copilots across complex workflows such as care management, utilization review, benefits coordination, and chart review.

不同于传统的自动化工具或通用的生成式AI平台，Autonomize AI提供了一个专为医疗领域打造的原生编排引擎。其预训练、可部署的AI代理在护理管理、使用审查、福利协调和病历审查等复杂工作流程中充当智能副驾角色。

These agents collaborate in a coordinated, multi-agent system designed to align with real-world healthcare operations—not just prompt-based responses..

这些代理在协调的多代理系统中协作，旨在与现实世界的医疗操作相一致，而不仅仅是基于提示的响应。

The platform is already deployed at scale within Fortune 100 healthcare enterprises, delivering measurable operational improvements:

该平台已经在财富100强的医疗企业中大规模部署，带来了可衡量的运营改进：

·       36,000 clinical hours saved per month by automating repetitive administrative tasks

·       每月通过自动化重复性管理任务节省36,000小时的临床时间

·       Over 100,000 automated care plans generated monthly to support higher-value patient interactions

每月生成超过100,000份自动化护理计划，以支持更高价值的患者互动。

·       Up to 50% faster decisions on prior authorizations and claims, accelerating patient access to care

·       对事先授权和索赔的决策速度提升高达50%，加快患者获得护理的速度

Autonomize AI distinguishes itself through enterprise-grade explainability, built-in transparency, and compliance-ready workflows. It supports regulated healthcare environments with human-in-the-loop systems, ensuring accountability and trust in every decision made by its agents.

Autonomize AI 通过企业级可解释性、内置透明度和合规就绪的工作流程脱颖而出。它通过人机协作系统支持受监管的医疗环境，确保其代理做出的每个决策都具有问责性和可信度。

As CEO Ganesh Padmanabhan stated, “The current healthcare system is no longer suited for the way care is delivered today—and too often, patients and clinicians pay the price in delayed treatment, wasted time, and unnecessary friction. Automation alone is not the answer for healthcare, but accountable, human-centered AI augmentation is.”.

正如首席执行官甘尼什·帕德玛纳班所说：“当前的医疗系统已不再适合当今医疗服务的提供方式——往往患者和医护人员都因治疗延误、时间浪费和不必要的摩擦而付出代价。单独的自动化并不是医疗行业的答案，但负责任的、以人为中心的人工智能增强才是。”

With strong traction across multiple healthcare and life sciences segments, Autonomize AI is uniquely positioned to drive scalable impact by solving high-friction, high-value operational challenges—ultimately making healthcare more accessible, efficient, and patient-centered.

凭借在多个医疗保健和生命科学领域的强大吸引力，Autonomize AI 通过解决高摩擦、高价值的运营挑战，具备推动可扩展影响的独特优势——最终使医疗保健更加便捷、高效且以患者为中心。